Related Image: Independent Study: OxiTitan VLR Antimicrobial Coating Kills Virus on Surfaces |
(Date:11/22/2009)...-USNewswire/ -- Congressman Chaka Fattah (D-PA) is...s Senate,s vote tonight to proceed to debate on Af...Arlen Specter and Bob Casey deserve the thanks of ...stand-up, critical votes in the Senate tonight adv...h Care Reform legislation to full debate. The Pres...
(Date:11/21/2009).../ -- Milvia Lopez, by her attorney MICHAEL STEWART...n Supreme Court, New York County, bearing Index # ...Lopez underwent a routine transesophageal echocard...s used an HIV infected scope exposing her to HIV. ...fter being discharged from the procedure and arriv...
(Date:11/21/2009)...l credentialing software company IntelliSoft Group...p with Amerinet, Inc., the leading healthcare G.P....sform quality care within the healthcare market. ...9 -- ISG Group, LLC, doing business as IntelliSoft...t Inc., a leading national healthcare group purcha...
(Date:11/21/2009)...l Group merges their practice with that of E. Stev... (PRWEB) November 21, 2009 -- The New H... Gibson, Dr. Dean Cloutier, Dr. John Plachtyna and...g practice with that of esteemed colleague Dr. E. ...nted to retire from dentistry in order to concentr...
(Date:11/20/2009)...ire-USNewswire/ -- The American Academy of Actuar...form legislation released this week to contain str...dual coverage mandate. The actuaries said that an ...verse selection stemming from more restrictive iss..."The individual mandate language should be strengt...
Breaking Medicine News(10 mins):Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:New Haven Dental Group Expands Their Vision 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2...ene Therapeutics Research Institute at Cedars-Sina...t it is possible to sustain therapeutic gene expre...ar, even in the presence of an anti-viral immune r...vel gutted adenoviral vector called HC-Adv, is com...
...rm outcomes, researchers say , THURSDAY, Oct. 25 (...rial natriuretic peptide (ANP) can lessen cardiac ...omes, a new study finds. , According to a Japanese...usion injuries," caused when blood rushes back to ...
...compare more than 500 health pla...26 U.S.News & World Report and the,National Commi...he third,edition of America,s Best Health Plans, a...families face health plan,selection options, the r...
...k Engineer and Information, Technology Magazines ..., ABBOTT PARK, Ill., Oct. 26 Abbott (NYSE: ABT ... diversity in two publications.,Abbott was named a...rsity in the magazine. In addition, Abbott was,nam...
...lth Plans, Lists for Third ...e third consecutive year,HealthPlus of Michigan,s ...,plans have been recognized by U.S. News & World R...are and Medicaid in the,national news magazine,s U...
...and,House Democratic leaders held a news conferenc...n the revised bipartisan SCHIP bill, which passed ...pening remarks:, "Today we took another step forw...ation where on the motion to recommit,the Republic...
Other Medicine News:Health News:U.S.News & World Report, NCQA Release Annual Rankings for 'America's Best Health Plans' 2Health News:U.S.News & World Report, NCQA Release Annual Rankings for 'America's Best Health Plans' 3Health News:Abbott Again Honored as a Leader in Diversity 2Health News:Abbott Again Honored as a Leader in Diversity 3... Poniard,Pharmaceuticals, Inc. (Nasdaq: PARD ), ...oday announced that it will present updated result...one-year survival data, during a,poster discussion...Study of,Lung Cancer,s (IASLC) 12th World Conferen... Poster number: PD6-1-1 Title: A phase 2 study o...
... (Nasdaq:,VICL) announced today that results from ...using a plasmid DNA (pDNA) vaccine developed by th...Vical, reinforced previously,reported Phase 1 conc...,vaccine regimen was safe and well-tolerated, and ...in up to 70% of the vaccine recipients. "These re...
Other Medicine Technology:Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer 2Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer 3Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 2Multiple NIH Phase 2 HIV Vaccine Trials Using Vical's Technology Produce Encouraging Results 3...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: